Abiopharma

🔍 Beer Marc D (Executive)

Company: biote Corp. (BTMD)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 115,950 shares of Class A Common Stock at $1.53 per share (Direct)
  Date: 2026-08-10 | Code: P | equity_swap_involved: 0 | shares_owned_after: 223,744.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 16,000 shares of Class A Common Stock at $1.55 per share (Direct)
  Date: 2026-08-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 239,744.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.